Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ board meetings

133 filed, newest first. Page 2 of 3.

Aug 2019
- 14 Aug · Board meeting
  We enclose herewith the Unaudited Financial Results of the Company for the quarter .... (opens in a new tab)
- 6 Aug · Board meeting
  To consider and approve the financial results for the quarter ended Jun 30, 2019 (opens in a new tab)
- 6 Aug · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
May 2019
- 24 May · Board meeting
  Financial Results for the year ended March 31, 2019 (opens in a new tab)
- 24 May · Board meeting
  Board meeting held on May 24, 2019. (opens in a new tab)
- 10 May · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2019 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 10 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019 (opens in a new tab)
Feb 2019
- 6 Feb · Board meeting
  Notice to consider and approve Unaudited Financial Results for the Quarter ended December 31, 2018.Pursuant to Regulation 29(1) (a) of the SEBI (Listing obligations and disclosure requirements) Regulations 2015, Unaudited Financial Results of the Company will be considered and approved for the quarter ended December 31, 2018 on Thursday, February 14, 2019 at the corporate office of the Company at 601, Proxima, Plot No. 19, Sector-30(A), Vashi, Navi Mumbai - 400705 at 3:00 P.M. (opens in a new tab)
- 6 Feb · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve In connection with the .... (opens in a new tab)
Nov 2018
- 2 Nov · Board meeting
  Intimation for Notice To Consider And Approve Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2018 On Wednesday November 14, 2018 At The Corporate Office Of The Company At 601, PROXIMA, Plot No.19, Sector-30(A) Vashi, Navi Mumbai-400705 At 3:00 P.M. (opens in a new tab)
- 2 Nov · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Intimation for Notice .... (opens in a new tab)
Aug 2018
- 14 Aug · Board meeting
  Financial Results for the quarter ended on June 30, 2018. (opens in a new tab)
- 7 Aug · Board meeting
  Notice to consider and approve Unaudited Financial Results for the quarter ended June 30, 2018 on Tuesday August 14, 2018 At the Corporate office of The Company At C-310/312, BSEL Tech Park, Opp. Vashi Railway Station, Navi Mumbai-400703 At 4:30 P.M. (opens in a new tab)
- 7 Aug · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve Notice to consider .... (opens in a new tab)
May 2018
- 31 May · Board meeting
  Financial Results for the quarter and year ended on March 31, 2018. (opens in a new tab)
- 22 May · Board meeting
  Notice to consider and approve Audited Financial Results for the quarter and year ended March 31, 2018 on Wednesday May 30, 2018 at the corporate office of the Company at C-310/312, BSEL Tech Park, Opp. Vashi Railway Station, Navi Mumbai-400703 at 2:00 P.M. (opens in a new tab)
Feb 2018
- 14 Feb · Board meeting
  Will consider the Unaudited Financial Results of the Company for the Quarter ended on June 30, 2017, September 30, 2017 and December 31, 2017. (opens in a new tab)
Dec 2017
- 1 Dec · Board meeting
  Will consider the Audited Financial Results for the Quarter and Year ended on March 31, 2017. (opens in a new tab)
Apr 2017
- 25 Apr · Board meeting
  Board of Directors of the Company at its meeting held on April 24, 2017 has took note of the following : Mr. Harish Palecanda and Dr. Nivedita Patil has tendered their resignation as an Independent Directors on the Board of the Company with effect from April 01, 2017. (opens in a new tab)
- 25 Apr · Board meeting
  Resignation of Mr. Harish Palecanda & Dr. Nivedita Patil as independent directors w.e.f 01 April,2017. (opens in a new tab)
Feb 2017
- 4 Feb · Board meeting
  (a) To take on record the Un-audited Financial Result for the Quarter ended December 31, 2016 along with the Limited Review Report. (b) Any other matter with the permission of the Chair. (opens in a new tab)
Nov 2016
- 14 Nov · Board meeting
  This is with reference to meeting of the Board of Directors of the Company held on November 13, 2016, The Company informed to Board of Directors that: .... (opens in a new tab)
- 3 Nov · Board meeting
  To take on record the Unaudited Financial Results for the Quarter ended September 30, 2016 along with the Limited Review Report; Any other matter with the permission of the Chair. (opens in a new tab)
Aug 2016
- 11 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 11, 2016, has decided the following : - Finalized the appointment .... (opens in a new tab)
- 11 Aug · Board meeting
  Outcome of Board Meeting of the Company held on August 11, 2016. (opens in a new tab)
- 1 Aug · Board meeting
  1 To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2016 along with the Limited Review Report; 2. To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2015-2016; 3. To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting; 4. To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the Annual General Meeting; 6. Any other matter with the permission of the Chair. (opens in a new tab)
Jun 2016
- 21 Jun · Board meeting
  Board of Directors of the Company at its meeting held on June 21, 2016, has: - Discussed the current financial position of the Company ....
- 21 Jun · Board meeting
  As decided in the Meeting of the Board of Directors of the Company held on June 21, 2016, for which intimation was already given to you, the Board of Directors: 1) Discussed the current financial position of the Company and decided to introduce more profitable products increase capacity utilization and get the business to move in the regulated markets specifically the United States of America. (opens in a new tab)
- 16 Jun · Board meeting
  To consider and discuss the overall financial viability of the Company. Any other matter with the permission of the Chair. (opens in a new tab)
May 2016
- 20 May · Board meeting
  1) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and nine months period ended March 31, 2016. 2) Any other matter with the permission of the Chair. (opens in a new tab)
Feb 2016
- 1 Feb · Board meeting
  To consider inter allia, adoption of Un-audited Financial Result for the Quarter ended on 31st December, 2015. (opens in a new tab)
Jan 2016
- 12 Jan · Board meeting
  Board of Directors of the Company at its meeting held on January 12, 2016, have discussed the below 1. Closure of the subsidiary ....
- 12 Jan · Board meeting
  Board of Directors at their meeting held on January 12, 2016 have discussed the below:1. Closure of the subsidiary company M/s Yusur International FZE.2. Acceptance of Resignation of Mr. Mohan Kala and Mr. Madhav Sapre from the office of Director w.e.f December 31, 2015. (opens in a new tab)
Oct 2015
- 29 Oct · Board meeting
  To consider inter allia, adoption of Un-audited Financial Result for the Quarter ended on September 30, 2015. (opens in a new tab)
Aug 2015
- 17 Aug · Board meeting
  To consider interalia, adoption of Audited Financial Result for the Quarter and Year ended as on June 30, 2015. (opens in a new tab)
Jun 2015
- 10 Jun · Board meeting
  Outcome of meeting of the Board of Directors of the Company held on June 10, 2015. (opens in a new tab)
- 10 Jun · Board meeting
  Board of Directors of the Company at its meeting held on June 10, 2015, has approved the allotment of 66,51,300 (Sixty Six Lacs Fifty One .... (opens in a new tab)
- 1 Jun · Board meeting
  For allotment of equity shares on account of conversion of warrants.
May 2015
- 4 May · Board meeting
  To consider inter alia, adoption of Un-audited Financial Results for the quarter ended on March 31, 2015.
Mar 2015
- 30 Mar · Board meeting
  Board of Directors of the Company at its meeting held on March 30, 2015, has approved the allotment of 67,15,400 (Sixty Seven Lacs Fifteen .... (opens in a new tab)
- 30 Mar · Board meeting
  Outcome of Board Meeting of the Company held on March 30, 2015. (opens in a new tab)
- 20 Mar · Board meeting
  For allotment of equity shares on account of conversion of warrants.
- 17 Mar · Board meeting
  Board of Directors of the Company at its meeting held on March 17, 2015 has decided to go with the restructuring of the debts of the Company.
- 16 Mar · Board meeting
  For the restructuring of the debts of the company. Due to fire in one of the plant of the Company in 2014, and non availability of the working capital to company, Company's management has decided to go for restructuring which at present, management of Company feels is the best option to Company. (opens in a new tab)
Feb 2015
- 4 Feb · Board meeting
  To consider inter-alia, adoption of un-audited Financial Results for the Quarter ended December 31, 2014.
Nov 2014
- 18 Nov · Board meeting
  To consider to recommend dividend for the year ended June 30, 2014 to be declared at ensuing general meeting. 1. Recommendation of dividend on 105569000 equity shares of Rs.2/ each fully paid up for the year ended 30"' June, 2014, subject to approval of the members at the ensuing Annual General Meeting. 2. The Dividend as recommended by the Board, if approved at the members at the Annual General meeting will be paid on or after the date of Annual General Meeting.
- 4 Nov · Board meeting
  To consider interalia, adoption of Un-audited Financial Result for the Quarter ended September 30, 2014.
Oct 2014
- 20 Oct · Board meeting
  Board of Directors of the Company at its Meeting held on October 20, 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter ....
- 20 Oct · Board meeting
  Board of Directors of the Company at its meeting held on October 20 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue of Capital and Disclosure Requirements) Regultions, 2009.
- 16 Oct · Board meeting
  For the allotment of 1,61,11,000 warrants on preferential basis.